Email
Menu News Products Video Webinars White Papers EDU

Pinnacle Biologics Acquires PDT Laser Tech

BANNOCKBURN, Ill., Dec. 5, 2012 — Pinnacle Biologics Inc. has completed its portfolio of photodynamic therapy (PDT) treatment components with the acquisition of Diomed’s PDT 630 laser and fiber optic diffuser Optiguide. Financial terms were not disclosed.

The privately-held biopharmaceutical company’s acquisitions are the only FDA-approved devices for use in PDT with Photofrin (porfimer sodium) for injection.

Photofrin — acquired by the company in March 2011 — is a two-stage process requiring administration of both drug and light. When injected, it is attracted to certain tissues, especially cancer cells, and is FDA-approved for the treatment of nonsmall-cell lung and esophageal cancer.

For more information, visit: www.pinnaclebiologics.com


The ability to post comments on Photonics.com is one benefit of a FREE Photonics.com membership.

Please login or register, for FREE, to post comments:

Login Register


Facebook Twitter RSS Mobile Apps